With further developments seen in COVID-19 treatment, the Department of Science and Technology (DOST) on Friday said that its other clinical trial on the use of virgin coconut oil is expected to end by May of next year.
DOST Usec. Rowena Guevara said that this trial refers to the one situated in the Philippine General Hospital (PGH) which houses severe and critical cases.
She said that approved participants will be given orally taken VCO after each meal three times a day for 14 days to assess whether it is effective in suppressing the virus from getting worse.
Earlier, DOST Sec. Fortunato Dela Peña said that the PGH management is having a hard time recruiting participants due to a decrease in the number of admitted severe COVID-19 patients.
On the other hand, its community-based trial in Laguna is bound to release its analysis by December of this year where from the 57 active subjects, 49 are already done with the study.
“Isinasagawa pa ang analysis at wala pang mailalabas na pahayag ukol sa obserbasyon sa study sa participants sa ngayon,” she said in a televised briefing.
In this group, she said that mild and suspected patients infected of COVID-19 are given food with mixed VCO that will undergo observation for 28 days.
Based on their initial laboratory findings, Guevara said experts found that VCO can reduce the number of SARS-CoV-2 by up to 60 to 90 percent but further study is needed to see its actual effects on infected individuals.